Star Bio Investments (Saskatoon, SK)

CMDF Investment: $3,960,000.00
Focus: Cancer  

Star Bio Invesments Inc. is an immunobiologicals company. It is dedicated to the development and commercialization of novel treatments for hormone-dependent cancers and other serious disorders. The Company's technology harnesses the immune system to control intercellular messengers; such as hormones; thereby achieving therapeutic effect. Initially; Star Bio is focused on developing hormone-regulatory therapies for prostate and breast cancer. However; a lead product - Norelin™ - was acquired by YM Biosciences Inc. Norelin is an immunopharmaceutical product based on a proprietary recombinant antigen; which harnesses the patient's own immune system to stimulate the development of antibodies to gonadotropin-releasing hormone (GnRH). The antibodies block the action of GnRH; a generally accepted therapeutic approach; which has therapeutic benefits for certain hormone-dependent cancers; such as prostate; breast; ovarian and uterine cancer.